Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Nalmefene in Patients With Alcohol Dependence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~In- and outpatients who:~* had a primary diagnosis of alcohol dependence according to Diagnostic and Statistical Manual of Mental Disorders - text revision (DSM-IV-TR) criteria~* had had ≥6 HDDs in the 4 weeks preceding the Screening Visit~* had had an average alcohol consumption at WHO medium risk level or above in the 4 weeks preceding the Screening Visit~Exclusion Criteria:~The patient:~* had a DSM-IV Axis I disorder other than alcohol dependence or nicotine dependence~* had an antisocial personality disorder~* had risk of suicide evaluated by the suicidality module of the Mini-International Neuropsychiatric Interview (MINI)~* had a history of delirium tremens or alcohol withdrawal seizures~* reported current or recent (within 3 months preceding screening) treatment with disulfiram, acamprosate, topiramate, naltrexone or carbimide, or with any opioid antagonists~* reported current or recent treatment with antipsychotics or antidepressants~* was pregnant or breast-feeding~Other protocol-defined inclusion and exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Nalmefene (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).